EANO guideline on molecular testing of meningiomas for targeted therapy selection.

Meningiomas are the most common primary intracranial tumors of adults. For meningiomas that progress or recur despite surgical resection and radiotherapy, additional treatment options are limited due to lack of proven efficacy. Meningiomas show recurring molecular aberrations, which may serve as predictive markers for systemic pharmacotherapies with targeted drugs or immunotherapy, radiotherapy or radioligand therapy.

Use of a nasal obturator of computer-aided design in managing hereditary hemorrhagic telangiectasia.

This clinical report describes the nonsurgical treatment of a patient suffering from severe epistaxis associated with hereditary hemorrhagic telangiectasia (HHT). Unlike the permanent surgical closure of the nostrils, known as the Young procedure, this treatment option provides interim relief from nasal obstruction. It includes the use of cone beam computed tomography (CBCT) and computer-aided design (CAD) to create a patient-specific silicone nasal obturator without the need for an impression of the nasal cavity, thereby preventing irritation to the delicate nasal mucosa that could instigate epistaxis.

Topical Antibiotic-Induced Otomycosis - a Systematic Review of Aetiology and Risk Factors.

Otomycosis is a chronic or subacute fungal infection of external ear accounting to 5 to 20% of external ear infection worldwide. Literature has suggested multiple local and environmental host factors associated with otomycosis, but their strength of association is not well established. We did this review to analyse otomycosis with respect to it's various common predisposing factors.

Translating the theranostic concept to neuro-oncology: disrupting barriers.

Theranostics integrate molecular imaging and targeted radionuclide therapy for personalised cancer therapy. Theranostic treatments have shown meaningful efficacy in randomised clinical trials and are approved for clinical use in prostate cancer and neuroendocrine tumours. Brain tumours represent an unmet clinical need and theranostics might offer effective treatment options, although specific issues need to be considered for clinical development.